Galapagos reported 199.82M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
AstraZeneca AZN:LN 7.09B 1.67B
Biogen BIIB:US $ 2289.3M 569.2M
Genmab GEN:DC 1.18B 136M
Gilead Sciences GILD:US $ 3971M 438M
GlaxoSmithKline GSK:LN 6.42B 692M
GRIFOLS GRF:SM 1.1B 129.52M
H. Lundbeck A/S LUN:DC 3.36B 27M
Hikma Pharmaceutical HIK:LN 873M 27M
Merck MRK:GR 3.82B 233M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Novartis NOVN:VX 9.82B 464M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
YTE INCY:US $ 564.87M 58.95M